Expert invitation
Approximately 90 international experts are invited to participate in the panel.
International Delphi consensus project
International Delphi Study in Mood Disorders
Treatment-emergent affective switch (TEAS) remains one of the most clinically relevant and inconsistently defined phenomena in mood disorders. This international Delphi study aims to develop a transparent, clinically useful consensus definition through structured expert consensus.
Treatment-emergent affective switch remains one of the most clinically significant and inconsistently defined phenomena in mood disorders. Differences across definitions complicate clinical decision-making, the interpretation of research findings, and comparison across studies.
The aim of this project is to develop a consensus operational definition of TEAS through an international Delphi process involving invited experts in bipolar disorder, psychopharmacology, and mood disorders.
The study is designed to balance expert judgment, methodological transparency, and practical clinical relevance.
Approximately 90 international experts are invited to participate in the panel.
Participants rate and comment on proposed operational criteria and related clinical domains.
Items are refined and re-rated based on aggregated expert feedback.
An additional round may be conducted if consensus requires further clarification.
The final definition and rationale are prepared for dissemination and publication.
The full protocol is available through OSF. The project will report its procedures, consensus thresholds, and final results in a transparent format suitable for peer review.
The study is an expert consensus project and does not involve patient recruitment, patient data collection, or clinical intervention. The study protocol has been reviewed and approved by the Independent Ethics Committee of the V.M. Bekhterev National Medical Research Center.
The final consensus definition is intended to support clinical research, future guideline discussions, and harmonized reporting across studies of mood disorders.
The project is coordinated by researchers with expertise in bipolar disorder, clinical psychopharmacology, psychiatric genomics, and consensus methodology.
Principal Research Fellow. Head, Department of Genomics of Mental Disorders.
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology.
Initiator and overall coordinator of the project.
PhD student, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Technical implementation and primary statistical analysis.
Associate Director for Innovative Scientific Development
Head of the Institute of Translational Psychiatry.
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology.
Associate Professor, Department of Psychiatry and Addiction, Saint Petersburg State University
Scientific Advisor to the study. Responsible for international coordination and expert communication.
Professor of Psychiatry, Dalhousie University, Canada
Internationally recognized expert in bipolar disorder and lithium treatment.
Scientific Advisor to the study.
Invited experts will complete short Delphi questionnaires and provide structured ratings and comments on proposed criteria.
Individual responses will be treated confidentially and reported in aggregate form for consensus analysis.
The final authorship and acknowledgement approach will be described in the study protocol and communicated transparently to participants.
For questions about the study protocol, expert participation, or project coordination, please contact the TEAS Consortium team.